Press Releases

Press Releases

  1. Arizona Patients Successfully Receive the World’s First Bioconvertible IVC Filter Commercially Offered In US

  2. Recommended Cash Offer for BTG plc by Boston Scientific Corporation

  3. BTG plc: Interim Results 2018

  4. BTG Sentry Bioconvertible IVC Filter 2-year Study Results Show Zero Tilt, Migration, Perforation, Fracture, or Embolization

  5. EKOS™ Control Unit 4.0 simplifies treatment of blood clots

  6. BTG plc: Directorate change

  7. BTG plc: close period update

  8. BTG Announces Replacement Policy for Expired CroFab®

  9. BTG announces global launch of the ICEfx™ Cryoablation System

  10. FDA Approves CroFab® Product Improvements

  11. BTG plc acquires Novate Medical Ltd.

  12. BTG receives not-approvable letter from the US FDA for ELEVAIR™

  13. OPTALYSE PE Results Published in JACC: Cardiovascular Interventions

  14. BTG plc: Annual General Meeting

  15. PERT Consortium and BTG Form Strategic Partnership

  16. Historical Financial Information Restated to US Dollars

  17. Result of FDA Advisory Committee vote on Elevair™ for the treatment of severe emphysema

  18. ELEVATE study aims to improve selection criteria and outcomes for patients with severe emphysema treated with the PneumRx™ Endobronchial Coil System

  19. BTG plc: Final Results 2018

  20. OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions

  21. BTG plc: close period update

  22. SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

  23. OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  24. Appointment of Non-executive Director